Clinical Trial Update: Evaluation of Efficacy and Safety of AVE5530 in Patients With Primary Hypercholesterolemia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating AVE5530 for primary hypercholesterolemia has been terminated. The update notes the assessment of its efficacy and safety prior…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• AVE5530

Snippet

Sponsor: Sanofi | Conditions: Hypercholesterolemia | Phase 3 | Status: TERMINATED